Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for In-process Sampling During Elixir Manufacturing – V 2.0

Posted on By

Elixir Department: SOP for In-process Sampling During Elixir Manufacturing – V 2.0

Standard Operating Procedure for In-process Sampling During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/061/2025
Supersedes SOP/ELX/061/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for systematic and representative in-process sampling during the manufacturing of elixirs to monitor quality attributes such as pH, appearance, assay, homogeneity, and microbial control.

2. Scope

This SOP is applicable to all batches of elixir formulations manufactured in the Elixir Department where in-process sampling is required before bulk filtration or packing.

3. Responsibilities

  • Production Operator:
    • Collect in-process samples as per instructions and aseptic practices.
    • Label and transfer samples to QA/QC for analysis.
  • QA Officer:
    • Verify sampling procedure and review in-process control results.
    • Authorize continuation or halt of processing based on results.
  • QC Analyst:
    • Perform pH, assay, and microbial tests as applicable.
    • Enter results in the In-process Test Report and communicate to QA.
See also  Elixir Department: SOP for Dispensing of Preservatives for Elixirs - V 2.0

4. Accountability

The QA Manager is accountable for ensuring sampling is representative and results are reviewed before next critical processing step.

5. Procedure

5.1 Sampling Plan

  1. Refer to the BMR or In-Process Control Plan for specific sampling time points.
  2. Typical sampling stages include:
    • After mixing/homogenization
    • Post pH adjustment
    • Before bulk filtration

5.2 Sampling Method

  1. Use clean and sterilized stainless steel or HDPE ladles and containers for sample collection.
  2. Collect samples from three points:
    • Top
    • Middle
    • Bottom
  3. Mix all three portions in a sterile container and label as “Composite Sample.”
  4. Label the container with:
    • Product Name
    • Batch Number
    • Date & Time of Sampling
    • Sample Point
    • Collected By
See also  Elixir Department: SOP for Verification of Raw Material Identity and Quantity - V 2.0

5.3 Tests Performed

  1. QC shall perform:
    • Appearance
    • pH
    • Assay (as per specification)
    • Microbial Limit (if required)

5.4 Documentation

  1. Record sample collection details in the In-process Sampling Log (Annexure-1).
  2. Attach In-process Test Report (Annexure-2) to BMR after QA review.

5.5 Precautions

  1. Ensure equipment used for sampling is sanitized.
  2. Do not open the tank for extended time to avoid microbial exposure.
  3. Do not return excess sample to the batch.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • QC: Quality Control
  • CFU: Colony Forming Unit

7. Documents

  1. In-process Sampling Log (Annexure-1)
  2. In-process Test Report (Annexure-2)
  3. Sampling Equipment Cleaning Log (Annexure-3)

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • WHO GMP Guidelines – Section 7: Production
See also  Elixir Department: SOP for Entry and Exit Procedure for Dispensing Area - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: In-process Sampling Log

Date Batch No. Sample Point Collected By Verified By
11/04/2025 ELX-1007 Composite (T/M/B) Rajesh Kumar Sunita Reddy

Annexure-2: In-process Test Report

Parameter Specification Result Status
Appearance Clear, colorless Clear Pass
pH 4.5–5.5 4.8 Pass
Assay 95%–105% 98.6% Pass

Annexure-3: Sampling Equipment Cleaning Log

Date Equipment ID Cleaned By Verified By Status
11/04/2025 SPL-01 Ajay Desai Manju Sharma Cleaned

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Issue New SOP QA Head
11/04/2025 2.0 Added Composite Sampling and Annexure Updates Compliance with WHO GMP QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Creams: SOP for Testing Creams for UV Protection Properties – V 2.0
Next Post: Aerosol: SOP for Verifying Utility System Performance During Process Changes – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version